Nabla Bio

Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics

Nabla to receive upfront and research cost payments in double-digit millions and eligible to receive success-based payments that may exceed $1 billion Multi-year partnership deploys Nabla Bio’s AI design and human-relevant wet-lab capabilities broadly across Takeda’s early-stage development programs New collaboration builds on success of first engagement as well as step-change improvements to Nabla Bio’s...
Riverside Technology Center
 840 Memorial Dr
 Cambridge, MA 02139